Lewis Au: Meet the Experts of VIRO 2025

The Global Voices in Renal Oncology (VIRO) Virtual Congress, organized by OncoDaily, will be held on September 11–12, 2025. Chaired by Dr. Rana R. McKay with co-chair Dr. Yüksel Ürün, this year’s program will feature around 50 leading experts in renal oncology from across the globe, sharing cutting-edge updates and future perspectives.

• The congress is free to attend.
• Register via the link.

Co-Chair of VIRO

Images

Name

Rana McKay Professor of Medicine and Urology at UC San Diego Health Co-leader of the GU Oncology Program at Moores Cancer Center As Co-Chair of VIRO, Dr. Rana McKay (University of California, San Diego) opened the congress with her talk on  “Future Directions: Emerging Agents and Combinations.” She emphasized the momentum in renal cell carcinoma (RCC) research, highlighting how novel immunotherapies, targeted drugs, and rational combination strategies are reshaping patient care. Dr. McKay underscored the importance of personalized, biomarker-driven approaches and global collaboration, aiming to optimize survival and quality of life worldwide.

Spotlight on Lewis Au

Dr. Lewis Au is a GU and General Medical Oncologist at Peter MacCallum Cancer Centre in Melbourne, Australia.

At the Global Voices in Renal Oncology (VIRO) Virtual Congress 2025, Dr. Au will present on “Overcoming Intratumour Heterogeneity in Tissue-Based Biomarkers in Clear Cell Renal Cell Carcinoma.” His presentation will explore:

• The challenges posed by intratumor heterogeneity in identifying predictive biomarkers.
• The development of RNA-based and molecular tests to predict immunotherapy response from single biopsies.
• Collaborative research efforts leveraging national biobanks and international partnerships to validate findings.
• The translation of biomarker research to clinically applicable tests that guide personalized treatment decisions.

Dr. Au’s translational research aims to deliver practical, scalable biomarker assays to improve patient outcomes through better treatment stratification in renal cell carcinoma.

Global Voices in Renal Oncology (VIRO) 2025